CLINICAL TRIALS PROFILE FOR MEASURIN
✉ Email this page to a colleague
All Clinical Trials for MEASURIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00983580 ↗ | Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer | Completed | National Cancer Institute (NCI) | Phase 2 | 2009-08-20 | This phase II trial is studying how well giving acetylsalicylic acid together with eflornithine works in treating patients at high risk for colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of acetylsalicylic acid and eflornithine may prevent colorectal cancer. |
| NCT02123849 ↗ | Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers | Completed | National Cancer Institute (NCI) | Phase 2 | 2014-06-01 | This randomized phase II trial studies the safety and effects of acetylsalicylic acid (aspirin) taken continuously or intermittently on gene expression in the nasal tissue of current smokers. Smokers are at increased risk of developing lung cancer. Acetylsalicylic acid may be useful in preventing lung cancer. |
| NCT02169271 ↗ | Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules | Completed | National Cancer Institute (NCI) | Phase 2 | 2014-11-21 | This randomized phase II trial studies acetylsalicylic acid compared to placebo in treating high-risk patients with subsolid lung nodules. A nodule is a growth or lump that may be malignant (cancer) or benign (not cancer). Chemoprevention is the use of drugs to keep cancer from forming or coming back. The use of acetylsalicylic acid may keep cancer from forming in patients with subsolid lung nodules. |
| NCT02348203 ↗ | Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers | Completed | National Cancer Institute (NCI) | Phase 2 | 2016-01-13 | This randomized phase II trial studies the effects of aspirin and zileuton on genes related to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to tobacco use and may be useful in preventing lung cancer in current smokers. |
| NCT02420652 ↗ | Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy | Terminated | National Cancer Institute (NCI) | Phase 2 | 2015-06-23 | This randomized phase II trial studies how well metformin hydrochloride and aspirin work in treating patients with hormone-dependent prostate cancer that has progressed after surgery or radiation therapy. Metformin hydrochloride and aspirin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether giving metformin hydrochloride and aspirin together can slow the growth of prostate cancer. |
| NCT02420652 ↗ | Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy | Terminated | Rutgers Cancer Institute of New Jersey | Phase 2 | 2015-06-23 | This randomized phase II trial studies how well metformin hydrochloride and aspirin work in treating patients with hormone-dependent prostate cancer that has progressed after surgery or radiation therapy. Metformin hydrochloride and aspirin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether giving metformin hydrochloride and aspirin together can slow the growth of prostate cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MEASURIN
Condition Name
Clinical Trial Locations for MEASURIN
Trials by Country
Clinical Trial Progress for MEASURIN
Clinical Trial Phase
Clinical Trial Sponsors for MEASURIN
Sponsor Name
